Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Urologic Neoplasms 1Intracranial Aneurysm 1Hemangioma, Cavernous 1Breast Neoplasms 1Arteriovenous Malformations 1

Interventions

pembrolizumab 3atezolizumab 2testosterone 17 beta-cypionate 1temsirolimus 1poly ICLC 1lenvatinib 1enfortumab vedotin 1Valproic Acid 1Testosterone Propionate 1Sunitinib 1Standard of Care 1Sirolimus 1Saline Solution 1Prednisone 1Practice Guidelines as Topic 1Methyltestosterone 1Immunoglobulin G 1Gemcitabine 1GSK-3326595 1Etoposide 1Doxycycline 1Docetaxel 1Disulfides 1Cyclophosphamide 1Cetuximab 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Urologic Neoplasms × Doxycycline × Clear all
NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
18 enrolled
BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡